title: Masquerade macular exudation in Mallatia Leventinese.
authors.affiliation: Sydney Retina Clinic & Day Surgery.
authors.forename: Shaun Y P
authors.initials: SY
authors.lastname: Ewe
authors.affiliation: Save Sight Institute, Sydney; Eye Genetics Research Group, Children's Medical Research Institute, University of Sydney, The Children's Hospital at Westmead; Discipline of Paediatrics and Child Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
authors.forename: Robyn
authors.initials: R
authors.lastname: Jamieson
authors.affiliation: Sydney Retina Clinic & Day Surgery; Save Sight Institute, Sydney. Electronic address: achang@sydneyretina.com.au.
authors.forename: Andrew A
authors.initials: AA
authors.lastname: Chang
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D020256:Choroidal Neovascularization / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D016326:Extracellular Matrix Proteins / Q000235:genetics; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D008875:Middle Aged; D017354:Point Mutation; D000069579:Ranibizumab / Q000627:therapeutic use; D015593:Retinal Drusen / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D055213:Retinal Pigment Epithelium / Q000473:pathology*; D058471:Subretinal Fluid; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014786:Vision Disorders / Q000175:diagnosis
chemical_list: D020533:Angiogenesis Inhibitors; C119630:EFEMP1 protein, human; D016326:Extracellular Matrix Proteins; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab